British Journal of Cancer - Table of Contents alert Volume 115 Issue 9

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 115, Issue 9 (1017-1156) Published online 25 October 2016 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Corrigenda Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Minireview Top The complexity of integrins in cancer and new scopes for therapeutic targeting Hellyeh Hamidi, Mika Pietilä and Johanna Ivaska Br J Cancer 2016 115: 1017-1023; advance online publication, September 29, 2016; 10.1038/bjc.2016.312 Abstract | Full Text Clinical Studies Top Axillary lymph node micrometastases decrease triple-negative early breast cancer survival G Houvenaeghel, R Sabatier, F Reyal, J M Classe, S Giard, H Charitansky, R Rouzier, C Faure, J R Garbay, E Daraï, D Hudry, P Gimbergues, R Villet and E Lambaudie Br J Cancer 2016 115: 1024-1031; advance online publication, September 29, 2016; 10.1038/bjc.2016.283 Abstract | Full Text Validation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder S D Kaupp-Roberts, G Yadegarfar, E Friend, C M O'Donnell, J W Valle, C Byrne, I Bahar, M Finch-Jones, R Gillmore, C D Johnson, S P Pereira, J K Wiggers, M Pinto, B Al-Sarireh and J K Ramage on behalf of the EORTC Quality of Life Group Br J Cancer 2016 115: 1032-1038; advance online publication, September 27, 2016; 10.1038/bjc.2016.284 Abstract | Full Text Intermediate-stage hepatocellular carcinoma treated with hepatic resection: the NSP score as an aid to decision-making Yong-Fa Zhang, Jie Zhou, Wei Wei, Ru-Hai Zou, Min-Shan Chen, Wan Yee Lau, Ming Shi and Rong-Ping Guo Br J Cancer 2016 115: 1039-1047; advance online publication, October 4, 2016; 10.1038/bjc.2016.301 Abstract | Full Text Factors associated with recurrence and survival length following relapse in patients with neuroblastoma Nermine O Basta, Gail C Halliday, Guy Makin, Jillian Birch, Richard Feltbower, Nick Bown, Martin Elliott, Lucas Moreno, Giuseppe Barone, Andrew DJ Pearson, Peter W James, Deborah A Tweddle and Richard JQ McNally Br J Cancer 2016 115: 1048-1057; advance online publication, October 4, 2016; 10.1038/bjc.2016.302 Abstract | Full Text Translational Therapeutics Top Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines Abdulazeez Salawu, Malee Fernando, David Hughes, Malcolm W R Reed, Penella Woll, Claire Greaves, Chris Day, Meshal Alhajimohammed and Karen Sisley Br J Cancer 2016 115: 1058-1068; advance online publication, August 25, 2016; 10.1038/bjc.2016.259 Abstract | Full Text Emergence of resistance to tyrosine kinase inhibitors in non-small-cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib Aurelie Courtin, Tomoko Smyth, Keisha Hearn, Harpreet K Saini, Neil T Thompson, John F Lyons and Nicola G Wallis Br J Cancer 2016 115: 1069-1077; advance online publication, September 27, 2016; 10.1038/bjc.2016.294 Abstract | Full Text Molecular Diagnostics Top Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study S E T Larkin, H E Johnston, T R Jackson, D G Jamieson, T I Roumeliotis, C I Mockridge, A Michael, A Manousopoulou, E K Papachristou, M D Brown, N W Clarke, H Pandha, C L Aukim-Hastie, M S Cragg, S D Garbis and P A Townsend Br J Cancer 2016 115: 1078-1086; advance online publication, September 29, 2016; 10.1038/bjc.2016.291 Abstract | Full Text Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial Jiaqi Huang, Alison M Mondul, Stephanie J Weinstein, Stella Koutros, Andriy Derkach, Edward Karoly, Joshua N Sampson, Steven C Moore, Sonja I Berndt and Demetrius Albanes Br J Cancer 2016 115: 1087-1095; advance online publication, September 27, 2016; 10.1038/bjc.2016.305 Abstract | Full Text A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma Ninna Aggerholm-Pedersen, Brita Singers Sørensen, Jens Overgaard, Kasper Toustrup, Steen Baerentzen, Ole Steen Nielsen, Katja Maretty-Kongstad, Marianne Nordsmark, Jan Alsner and Akmal Safwat Br J Cancer 2016 115: 1096-1104; advance online publication, October 4, 2016; 10.1038/bjc.2016.310 Abstract | Full Text Epidemiology Top Breast cancer risk and protracted low-to-moderate dose occupational radiation exposure in the US Radiologic Technologists Cohort, 1983–2008 D L Preston, C M Kitahara, D M Freedman, A J Sigurdson, S L Simon, M P Little, E K Cahoon, P Rajaraman, J S Miller, B H Alexander, M M Doody and M S Linet Br J Cancer 2016 115: 1105-1112; advance online publication, September 13, 2016; 10.1038/bjc.2016.292 Abstract | Full Text Dietary exposure to polychlorinated biphenyls and risk of breast, endometrial and ovarian cancer in a prospective cohort Carolina Donat-Vargas, Agneta Åkesson, Marika Berglund, Anders Glynn, Alicja Wolk and Maria Kippler Br J Cancer 2016 115: 1113-1121; advance online publication, September 15, 2016; 10.1038/bjc.2016.282 Abstract | Full Text Dairy, calcium, vitamin D and ovarian cancer risk in African–American women Bo Qin, Patricia G Moorman, Anthony J Alberg, Jill S Barnholtz-Sloan, Melissa Bondy, Michele L Cote, Ellen Funkhouser, Edward S Peters, Ann G Schwartz, Paul Terry, Joellen M Schildkraut and Elisa V Bandera Br J Cancer 2016 115: 1122-1130; advance online publication, September 15, 2016; 10.1038/bjc.2016.289 Abstract | Full Text Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers Jyoti Malhotra, Tim Waterboer, Michael Pawlita, Angelika Michel, Qiuyin Cai, Wei Zheng, Yu-Tang Gao, Qing Lan, Nathaniel Rothman, Hilde Langseth, Tom K Grimsrud, Jian-Min Yuan, Woon-Puay Koh, Renwei Wang, Alan A Arslan, Anne Zeleniuch-Jacquotte and Paolo Boffetta Br J Cancer 2016 115: 1131-1139; advance online publication, September 15, 2016; 10.1038/bjc.2016.285 Abstract | Full Text Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study Rebecca Landy, Francesca Pesola, Alejandra Castañón and Peter Sasieni Br J Cancer 2016 115: 1140-1146; advance online publication, September 15, 2016; 10.1038/bjc.2016.290 Abstract | Full Text Cancer incidence and mortality projections in the UK until 2035 C R Smittenaar, K A Petersen, K Stewart and N Moitt Br J Cancer 2016 115: 1147-1155; advance online publication, October 11, 2016; 10.1038/bjc.2016.304 Abstract | Full Text Corrigenda Top Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death I Obiorah, S Sengupta, P Fan and V C Jordan Br J Cancer 2016 115: e10; advance online publication, October 6, 2016; 10.1038/bjc.2016.298 Full Text Impaired T-bet-pSTAT1α and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma Katerina Andreev, Denis Iulian Trufa, Raphaela Siegemund, Ralf Rieker, Arndt Hartmann, Joachim Schmidt, Horia Sirbu and Susetta Finotto Br J Cancer 2016 115: e11; advance online publication, September 22, 2016; 10.1038/bjc.2016.299 Full Text Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines D A Tonetti, M J Chisamore, W Grdina, H Schurz and V C Jordan Br J Cancer 2016 115: e12; advance online publication, September 22, 2016; 10.1038/bjc.2016.297 Full Text Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer E Gabriela Chiorean, Daniel D Von Hoff, Josep Tabernero, Robert El-Maraghi, Wen Wee Ma, Michele Reni, Marion Harris, Robert Whorf, Helen Liu, Jack Shiansong Li, Victoria Manax, Alfredo Romano, Brian Lu and David Goldstein Br J Cancer 2016 115: e13; advance online publication, September 22, 2016; 10.1038/bjc.2016.306 Full Text Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity A Tittarelli, I Guerrero, F Tempio, M A Gleisner, I Avalos, S Sabanegh, C Ortíz, L Michea, M N López, A Mendoza-Naranjo and F Salazar-Onfray Br J Cancer 2016 115: e14; advance online publication, September 22, 2016; 10.1038/bjc.2016.296 Full Text HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia Anne Ørbo, Marit Arnes, Lena Myreng Lyså, Christer Borgfeldt and Bjørn Straume Br J Cancer 2016 115: e15; advance online publication, October 6, 2016; 10.1038/bjc.2016.330 Full Text Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer Angus G Dalgleish, Justin Stebbing, Douglas J A Adamson, Seema Safia Arif, Paolo Bidoli, David Chang, Sue Cheeseman, Robert Diaz-Beveridge, Carlos Fernandez-Martos, Rob Glynne-Jones, Cristina Granetto, Bartomeu Massuti, Karen McAdam, Raymond McDermott, Andrés J Muñoz Martín, Demetris Papamichael, Roberto Pazo-Cid, Jose M Vieitez, Alberto Zaniboni, Kevin J Carroll, Shama Wagle, Andrew Gaya and Satvinder S Mudan Br J Cancer 2016 115: e16; advance online publication, October 11, 2016; 10.1038/bjc.2016.342 Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.